Skip to content

RealTime CMV Assay

by Abbott Molecular

PMA P160044

RealTime CMV Assay is a medical device (FDA Class II; FDA product code PAB, Cytomegalovirus (Cmv) Dna Quantitative Assay) made by Abbott Molecular, approved under FDA PMA P160044 on 18 May 2017, active as of 11 Oct 2026.

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 11 Oct 2026

Documents

PMA P160044↗

FDA record

Trust

Unverified

Source FDA PMA, synced 11 Oct 2026.

Regulatory status

as of registry sync 11 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPRL NumberP160044 Date18 May 2017DecidedStatusActive

Official records

From the FDA record

FDA PMA P160044

Received by the FDA
4 Oct 2016
FDA decision
18 May 2017
FDA review time
226 days from receipt to decision
Docket number
17M-3200
Approval order statement, verbatim
Approval for the Abbott RealTime CMV test is an in vitro polymerase chain reaction (PCR) assay for the quantitation of cytomegalovirus (CMV) DNA in human EDTA plasma. The Abbott RealTime CMV test is intended for use as an aid in the management of Hematopoietic Stem Cell Transplant patients who are undergoing anti-cytomegalovirus therapy. In this population, serial DNA measurement can be used to assess virological response to anti-cytomegalovirus therapy. The results from the RealTime CMV test must be interpreted within the context of all relevant clinical and laboratory findings. The RealTime CMV test is not intended as a screening test for the presence of CMV DNA in blood or blood products.

From the FDA PMA record P160044 (openFDA), as read on 11 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Trade name
Abbott Realtime Cmv
Generic name
Cytomegalovirus (cmv) dna quantitative assay
PMA number
FDA product code
PAB
Device class
Class II
Regulation
21 CFR Part 866.3180
Advisory committee
Microbiology
FDA decision
APRL

Devices cleared under P160044

4 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under P160044
UDI-DISize and differences
RealTime 09N21-002
Abbott Molecular
09N21-002 / 09N21-00200884999047297
Single use: no
On the market
RealTime 09N21-070
Abbott Molecular
09N21-070 / 09N21-07000884999045774
Single use: yes
On the market
RealTime 09N21-080
Abbott Molecular
09N21-080 / 09N21-08000884999045781
Single use: yes
On the market
RealTime 09N21-090
Abbott Molecular
09N21-090 / 09N21-09000884999045798
Single use: yes
On the market

Similar devices

Other devices filed under FDA product code PAB (Cytomegalovirus (Cmv) Dna Quantitative Assay).

Other devices from Abbott Molecular

See all devices from Abbott Molecular →